DJIA 16,563.30 -317.06 -1.88%
NASDAQ 4,369.77 -93.13 -2.09%
S&P 500 1,930.67 -39.40 -2.00%
market minute promo

Genomic Health (NASDAQ: GHDX)

25.48 -0.87 (-3.30%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GHDX $25.48 -3.30%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $25.90
Previous Close $26.35
Daily Range $25.43 - $26.28
52-Week Range $23.90 - $37.24
Market Cap $796.1M
P/E Ratio -41.83
Dividend (Yield) $0.00 (0.0%)
Volume 96,376
Average Daily Volume 162,130
Current FY EPS -$0.88




Healthcare Information Services

Genomic Health (GHDX) Description

Genomic Health's diagnostic tests offer innovative cancer screening. Website:

News & Commentary

How 23andMe Can Spur Growth for These Diagnostics Companies

Direct-to-consumer genetic tests took a hit when the Food and Drug Administration told 23andMe to stop marketing its product. However, accepting the arrival of accessible genetic information could ignite growth opportunities for Myriad Genetics, Genomic Health, and Quest Diagnostics.

Will Cigna (CI) Beat Q2 Earnings on ACO & Global Business? - Analyst Blog

Is NanoString The Next Illumina In Cancer Diagnostics?

Genomic Grows on Breast Cancer Test, Margin Pressure Continues - Analyst Blog

Genomic Health's Oncotype DX Redefines Breast Cancer Therapy - Analyst Blog

Genomic Health Up on Fresh Cancer Study Data - Analyst Blog

Genomic Health Announces Presented Two Studies at ASCO Related to Oncotype DX(R) Test

Genomic Health Posts Fresh Oncotype DX Data - Analyst Blog

Genomic Health: Study Boosts Oncotype DX Again - Analyst Blog

Genomic Health Presents New Oncotype DX Data - Analyst Blog

Genomic Health Presents New Oncotype DX Data - Analyst Blog

Q1 Loss Wider than Expected at Genomic Health - Analyst Blog

See More GHDX News...

GHDX's Top Competitors

GHDX $25.48 (-3.30%)
Current stock: GHDX
AMGN $127.39 (-2.02%)
Current stock: AMGN
GILD $91.55 (-2.39%)
Current stock: GILD
BIIB $334.39 (-2.94%)
Current stock: BIIB